| 1 | Pipeline Completion Summary | Table with step scores (literature_scan, gap_analysis, hypothesis_generation, knowledge_entry) + score evolution (HG→KE delta + rationale) | All prior steps |
| 2 | 6-Dimension Quality Scoring | Weighted scoring table with 6 dimensions (see reference knowledge-entry-rubric.md). Each dimension needs score + rationale paragraph. Show weighted total calculation. | Novel synthesis |
| 3 | Domain Overview | Natural history of the physiological system (3-5 paragraphs), clinical problem table (condition, prevalence, existing metric, gap), white space statement, "why now" justification | literature_scan + gap_analysis |
| 4 | Model Architecture | 2-ODE+PINN description: ODE-1 and ODE-2 dynamics (state vars, parameters, key behavior). ASCII diagram or equation blocks. Multi-scale temporal assessment table. Cross-ODE identifiability confound analysis (detection→assessment→mitigation→residual). | gap_analysis |
| 5 | Entity Extraction | Two tables: (a) Entities — name, type, description for all physiological systems, diseases, parameters, devices, kernels; (b) Relations — source, relation, target for structural_analog/neighbor, clinical_biomarker, integrates, etc. | All prior steps |
| 6 | Hypothesis Portfolio | Ranked table (rank, ID, title, composite, recommendation) + detailed description of primary hypothesis (statement, population, measurement, endpoint, rejection criteria, rationale) + discriminative experiment design (Pattern #5 phase table) | hypothesis_generation |
| 7 | Kernel Registration | Structured table: kernel ID, name, type, domain, state/parameters, dynamics, clinical inputs, connected kernels, unique contribution, clinical conditions | Novel synthesis |
| 8 | Clinical Translation & Market | Phase 1-4 pathway table (timeline, activity, success criterion). Addressable populations table (population, size, current test, PINN advantage). Zero-equipment justification. | gap_analysis + hypothesis_generation |
| 9 | Critical Assessment & Limitations | Star-rating table (novelty, data feasibility, clinical impact, model complexity, parameter identifiability, reproducibility) + key risks (3-5 items, each with mitigation). Pipeline completion summary (domain expansion trajectory, next actions). | All prior steps |